The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial

EuroIntervention 2014;10:204-211. DOI: 10.4244/EIJV10I2A34

1. CHU de Liège, Liège, Belgium; 2. Cardiovascular Center Aalst OLV-Clinic, Aalst, Belgium; 3. CHU Mont Godinne, Godinne, Belgium; 4. St Jan Ziekenhuis Genk, Genk, Belgium; 5. CHR Citadelle Liège, Liège, Belgium; 6. UZ Antwerpen, Antwerp, Belgium

Aims: The Stent Thrombosis In Belgium (STIB) trial aimed to determine whether assessing platelet reactivity (PR) in patients with stable coronary artery disease undergoing elective percut

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial